Stock listing
ELUT Stock Price, News, Filings & Events — Elutia, Inc.
Selected listing: ELUT · NASDAQ · USD · US
This page tracks Elutia, Inc.'s ELUT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ELUT:NASDAQ. ELUT:NASDAQ is the stock-level entry point for investors researching Elutia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elutia, Inc. (ticker: ELUT) is a public company based in America with a market capitalization of approximately $41.1 million. The company operates in the biotechnology sector, focusing on innovative solutions in healthcare. Elutia aims to advance its technologies and expand its presence in the market.
- Ticker
- ELUT:NASDAQ
- Asset type
- Stock
- Market cap
- $36.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Elutia, Inc. ELUT:NASDAQ stock context
This page tracks Elutia, Inc.'s ELUT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ELUT:NASDAQ. ELUT:NASDAQ is the stock-level entry point for investors researching Elutia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elutia, Inc. (ticker: ELUT) is a public company based in America with a market capitalization of approximately $41.1 million. The company operates in the biotechnology sector, focusing on innovative solutions in healthcare. Elutia aims to advance its technologies and expand its presence in the market.
Latest news from Elutia, Inc.
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
October 1, 2026
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
September 10, 2026
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
August 13, 2026
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
July 31, 2026
Elutia, Inc. earnings calls
Elutia, Inc. (ELUT) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Elutia, Inc. (ELUT) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Elutia, Inc. (ELUT) Q4 2025 Earnings Call
March 11, 2026 · Replay with transcript and chapters
Elutia, Inc. (ELUT) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Elutia, Inc. (ELUT) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Elutia, Inc. (ELUT) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Elutia, Inc.
Elutia, Inc. investor report
Review AI stock analysis and investor report context for ELUT:NASDAQ.
Elutia, Inc. company profile
View the public company page for Elutia, Inc. on 6ix.
Elutia, Inc. news
Read company news and market updates connected to Elutia, Inc..
Elutia, Inc. investor events
Find investor webinars, events, and replay context for Elutia, Inc..